Skip to search formSkip to main contentSkip to account menu

afimoxifene

Known as: 4-OHT, para-hydroxytamoxifen, 4OH-tamoxifen 
A form of the drug tamoxifen that is made by the body after taking tamoxifen. It can also be made in the laboratory, and may help decrease breast… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
De novo insensitivity and acquired resistance to the selective oestrogen receptor modulator tamoxifen and the pure anti-oestrogen… 
Highly Cited
2003
Highly Cited
2003
Estrogen receptor (ER)alpha and -beta interact with a variety of coactivator proteins, most notably members of the steroid… 
Highly Cited
2002
Highly Cited
2002
A human protein termed p21-activated kinase 6 (PAK6), based on homology to the PAK family of serine/threonine kinases, was cloned… 
Highly Cited
1999
Highly Cited
1999
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) exerts its toxic action via the aryl hydrocarbon (Ah) receptor, which induces a… 
Highly Cited
1996
Highly Cited
1996
We have developed an animal tumor model system to study the effects of c-Myc activation on apoptosis induction in vivo. Tumors… 
Highly Cited
1995
Highly Cited
1995
Many tumours in endocrine‐sensitive tissues, such as the breast and endometrium, are hormone‐dependent and the hydrolysis of… 
Highly Cited
1990
Highly Cited
1990
The antiestrogen tamoxifen and the aromatase inhibitor aminoglutethimide show similar response rates when used in the endocrine… 
Highly Cited
1989
Highly Cited
1989
The effects of tamoxifen, three of its in vivo metabolites and 3-hydroxytamoxifen on cellular proliferation and the induction of… 
Highly Cited
1985
Highly Cited
1985
In the exploration of the structural features that affect the RBA (binding affinity for the estrogen receptor of rat uterus…